Global Efinaconazole Market Growth 2025-2031

December 2025 | 83 pages | ID: G7F29A6C9CFEN
LP Information

Abstracts

The global Efinaconazole market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Efinaconazole is a 14 alpha-demethylase inhibitor indicated in the treatment of fungal infection of the nail, known as onychomycosis.

United States market for Efinaconazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Efinaconazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Efinaconazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Efinaconazole players cover Viruj Pharma, Zhejiang Aoxiang Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Efinaconazole Industry Forecast” looks at past sales and reviews total world Efinaconazole sales in 2024, providing a comprehensive analysis by region and market sector of projected Efinaconazole sales for 2025 through 2031. With Efinaconazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Efinaconazole industry.

This Insight Report provides a comprehensive analysis of the global Efinaconazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Efinaconazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Efinaconazole market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Efinaconazole and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Efinaconazole.

This report presents a comprehensive overview, market shares, and growth opportunities of Efinaconazole market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Purity Above 98%
• Purity Below 98%

Segmentation by Application:

• Onychomycosis
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Viruj Pharma
• Zhejiang Aoxiang Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Efinaconazole market?

What factors are driving Efinaconazole market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Efinaconazole market opportunities vary by end market size?

How does Efinaconazole break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Efinaconazole Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Efinaconazole by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Efinaconazole by Country/Region, 2020, 2024 & 2031
2.2 Efinaconazole Segment by Type
  2.2.1 Purity Above 98%
  2.2.2 Purity Below 98%
2.3 Efinaconazole Sales by Type
  2.3.1 Global Efinaconazole Sales Market Share by Type (2020-2025)
  2.3.2 Global Efinaconazole Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Efinaconazole Sale Price by Type (2020-2025)
2.4 Efinaconazole Segment by Application
  2.4.1 Onychomycosis
  2.4.2 Other
2.5 Efinaconazole Sales by Application
  2.5.1 Global Efinaconazole Sale Market Share by Application (2020-2025)
  2.5.2 Global Efinaconazole Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Efinaconazole Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Efinaconazole Breakdown Data by Company
  3.1.1 Global Efinaconazole Annual Sales by Company (2020-2025)
  3.1.2 Global Efinaconazole Sales Market Share by Company (2020-2025)
3.2 Global Efinaconazole Annual Revenue by Company (2020-2025)
  3.2.1 Global Efinaconazole Revenue by Company (2020-2025)
  3.2.2 Global Efinaconazole Revenue Market Share by Company (2020-2025)
3.3 Global Efinaconazole Sale Price by Company
3.4 Key Manufacturers Efinaconazole Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Efinaconazole Product Location Distribution
  3.4.2 Players Efinaconazole Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR EFINACONAZOLE BY GEOGRAPHIC REGION

4.1 World Historic Efinaconazole Market Size by Geographic Region (2020-2025)
  4.1.1 Global Efinaconazole Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Efinaconazole Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Efinaconazole Market Size by Country/Region (2020-2025)
  4.2.1 Global Efinaconazole Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Efinaconazole Annual Revenue by Country/Region (2020-2025)
4.3 Americas Efinaconazole Sales Growth
4.4 APAC Efinaconazole Sales Growth
4.5 Europe Efinaconazole Sales Growth
4.6 Middle East & Africa Efinaconazole Sales Growth

5 AMERICAS

5.1 Americas Efinaconazole Sales by Country
  5.1.1 Americas Efinaconazole Sales by Country (2020-2025)
  5.1.2 Americas Efinaconazole Revenue by Country (2020-2025)
5.2 Americas Efinaconazole Sales by Type (2020-2025)
5.3 Americas Efinaconazole Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Efinaconazole Sales by Region
  6.1.1 APAC Efinaconazole Sales by Region (2020-2025)
  6.1.2 APAC Efinaconazole Revenue by Region (2020-2025)
6.2 APAC Efinaconazole Sales by Type (2020-2025)
6.3 APAC Efinaconazole Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Efinaconazole by Country
  7.1.1 Europe Efinaconazole Sales by Country (2020-2025)
  7.1.2 Europe Efinaconazole Revenue by Country (2020-2025)
7.2 Europe Efinaconazole Sales by Type (2020-2025)
7.3 Europe Efinaconazole Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Efinaconazole by Country
  8.1.1 Middle East & Africa Efinaconazole Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Efinaconazole Revenue by Country (2020-2025)
8.2 Middle East & Africa Efinaconazole Sales by Type (2020-2025)
8.3 Middle East & Africa Efinaconazole Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Efinaconazole
10.3 Manufacturing Process Analysis of Efinaconazole
10.4 Industry Chain Structure of Efinaconazole

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Efinaconazole Distributors
11.3 Efinaconazole Customer

12 WORLD FORECAST REVIEW FOR EFINACONAZOLE BY GEOGRAPHIC REGION

12.1 Global Efinaconazole Market Size Forecast by Region
  12.1.1 Global Efinaconazole Forecast by Region (2026-2031)
  12.1.2 Global Efinaconazole Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Efinaconazole Forecast by Type (2026-2031)
12.7 Global Efinaconazole Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Viruj Pharma
  13.1.1 Viruj Pharma Company Information
  13.1.2 Viruj Pharma Efinaconazole Product Portfolios and Specifications
  13.1.3 Viruj Pharma Efinaconazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Viruj Pharma Main Business Overview
  13.1.5 Viruj Pharma Latest Developments
13.2 Zhejiang Aoxiang Pharmaceutical
  13.2.1 Zhejiang Aoxiang Pharmaceutical Company Information
  13.2.2 Zhejiang Aoxiang Pharmaceutical Efinaconazole Product Portfolios and Specifications
  13.2.3 Zhejiang Aoxiang Pharmaceutical Efinaconazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Zhejiang Aoxiang Pharmaceutical Main Business Overview
  13.2.5 Zhejiang Aoxiang Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Efinaconazole Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Efinaconazole Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity Above 98%
Table 4. Major Players of Purity Below 98%
Table 5. Global Efinaconazole Sales by Type (2020-2025) & (MT)
Table 6. Global Efinaconazole Sales Market Share by Type (2020-2025)
Table 7. Global Efinaconazole Revenue by Type (2020-2025) & ($ million)
Table 8. Global Efinaconazole Revenue Market Share by Type (2020-2025)
Table 9. Global Efinaconazole Sale Price by Type (2020-2025) & (USD/Kg)
Table 10. Global Efinaconazole Sale by Application (2020-2025) & (MT)
Table 11. Global Efinaconazole Sale Market Share by Application (2020-2025)
Table 12. Global Efinaconazole Revenue by Application (2020-2025) & ($ million)
Table 13. Global Efinaconazole Revenue Market Share by Application (2020-2025)
Table 14. Global Efinaconazole Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Efinaconazole Sales by Company (2020-2025) & (MT)
Table 16. Global Efinaconazole Sales Market Share by Company (2020-2025)
Table 17. Global Efinaconazole Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Efinaconazole Revenue Market Share by Company (2020-2025)
Table 19. Global Efinaconazole Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Efinaconazole Producing Area Distribution and Sales Area
Table 21. Players Efinaconazole Products Offered
Table 22. Efinaconazole Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Efinaconazole Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Efinaconazole Sales Market Share Geographic Region (2020-2025)
Table 27. Global Efinaconazole Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Efinaconazole Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Efinaconazole Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Efinaconazole Sales Market Share by Country/Region (2020-2025)
Table 31. Global Efinaconazole Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Efinaconazole Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Efinaconazole Sales by Country (2020-2025) & (MT)
Table 34. Americas Efinaconazole Sales Market Share by Country (2020-2025)
Table 35. Americas Efinaconazole Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Efinaconazole Sales by Type (2020-2025) & (MT)
Table 37. Americas Efinaconazole Sales by Application (2020-2025) & (MT)
Table 38. APAC Efinaconazole Sales by Region (2020-2025) & (MT)
Table 39. APAC Efinaconazole Sales Market Share by Region (2020-2025)
Table 40. APAC Efinaconazole Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Efinaconazole Sales by Type (2020-2025) & (MT)
Table 42. APAC Efinaconazole Sales by Application (2020-2025) & (MT)
Table 43. Europe Efinaconazole Sales by Country (2020-2025) & (MT)
Table 44. Europe Efinaconazole Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Efinaconazole Sales by Type (2020-2025) & (MT)
Table 46. Europe Efinaconazole Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Efinaconazole Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Efinaconazole Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Efinaconazole Sales by Type (2020-2025) & (MT)
Table 50. Middle East & Africa Efinaconazole Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Efinaconazole
Table 52. Key Market Challenges & Risks of Efinaconazole
Table 53. Key Industry Trends of Efinaconazole
Table 54. Efinaconazole Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Efinaconazole Distributors List
Table 57. Efinaconazole Customer List
Table 58. Global Efinaconazole Sales Forecast by Region (2026-2031) & (MT)
Table 59. Global Efinaconazole Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Efinaconazole Sales Forecast by Country (2026-2031) & (MT)
Table 61. Americas Efinaconazole Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Efinaconazole Sales Forecast by Region (2026-2031) & (MT)
Table 63. APAC Efinaconazole Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Efinaconazole Sales Forecast by Country (2026-2031) & (MT)
Table 65. Europe Efinaconazole Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Efinaconazole Sales Forecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Efinaconazole Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Efinaconazole Sales Forecast by Type (2026-2031) & (MT)
Table 69. Global Efinaconazole Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Efinaconazole Sales Forecast by Application (2026-2031) & (MT)
Table 71. Global Efinaconazole Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Viruj Pharma Basic Information, Efinaconazole Manufacturing Base, Sales Area and Its Competitors
Table 73. Viruj Pharma Efinaconazole Product Portfolios and Specifications
Table 74. Viruj Pharma Efinaconazole Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Viruj Pharma Main Business
Table 76. Viruj Pharma Latest Developments
Table 77. Zhejiang Aoxiang Pharmaceutical Basic Information, Efinaconazole Manufacturing Base, Sales Area and Its Competitors
Table 78. Zhejiang Aoxiang Pharmaceutical Efinaconazole Product Portfolios and Specifications
Table 79. Zhejiang Aoxiang Pharmaceutical Efinaconazole Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Zhejiang Aoxiang Pharmaceutical Main Business
Table 81. Zhejiang Aoxiang Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Efinaconazole
Figure 2. Efinaconazole Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Efinaconazole Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Efinaconazole Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Efinaconazole Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Efinaconazole Sales Market Share by Country/Region (2024)
Figure 10. Efinaconazole Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity Above 98%
Figure 12. Product Picture of Purity Below 98%
Figure 13. Global Efinaconazole Sales Market Share by Type in 2025
Figure 14. Global Efinaconazole Revenue Market Share by Type (2020-2025)
Figure 15. Efinaconazole Consumed in Onychomycosis
Figure 16. Global Efinaconazole Market: Onychomycosis (2020-2025) & (MT)
Figure 17. Efinaconazole Consumed in Other
Figure 18. Global Efinaconazole Market: Other (2020-2025) & (MT)
Figure 19. Global Efinaconazole Sale Market Share by Application (2024)
Figure 20. Global Efinaconazole Revenue Market Share by Application in 2025
Figure 21. Efinaconazole Sales by Company in 2025 (MT)
Figure 22. Global Efinaconazole Sales Market Share by Company in 2025
Figure 23. Efinaconazole Revenue by Company in 2025 ($ millions)
Figure 24. Global Efinaconazole Revenue Market Share by Company in 2025
Figure 25. Global Efinaconazole Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Efinaconazole Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Efinaconazole Sales 2020-2025 (MT)
Figure 28. Americas Efinaconazole Revenue 2020-2025 ($ millions)
Figure 29. APAC Efinaconazole Sales 2020-2025 (MT)
Figure 30. APAC Efinaconazole Revenue 2020-2025 ($ millions)
Figure 31. Europe Efinaconazole Sales 2020-2025 (MT)
Figure 32. Europe Efinaconazole Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Efinaconazole Sales 2020-2025 (MT)
Figure 34. Middle East & Africa Efinaconazole Revenue 2020-2025 ($ millions)
Figure 35. Americas Efinaconazole Sales Market Share by Country in 2025
Figure 36. Americas Efinaconazole Revenue Market Share by Country (2020-2025)
Figure 37. Americas Efinaconazole Sales Market Share by Type (2020-2025)
Figure 38. Americas Efinaconazole Sales Market Share by Application (2020-2025)
Figure 39. United States Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Efinaconazole Sales Market Share by Region in 2025
Figure 44. APAC Efinaconazole Revenue Market Share by Region (2020-2025)
Figure 45. APAC Efinaconazole Sales Market Share by Type (2020-2025)
Figure 46. APAC Efinaconazole Sales Market Share by Application (2020-2025)
Figure 47. China Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 51. India Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Efinaconazole Sales Market Share by Country in 2025
Figure 55. Europe Efinaconazole Revenue Market Share by Country (2020-2025)
Figure 56. Europe Efinaconazole Sales Market Share by Type (2020-2025)
Figure 57. Europe Efinaconazole Sales Market Share by Application (2020-2025)
Figure 58. Germany Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 59. France Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Efinaconazole Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Efinaconazole Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Efinaconazole Sales Market Share by Application (2020-2025)
Figure 66. Egypt Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Efinaconazole Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Efinaconazole in 2025
Figure 72. Manufacturing Process Analysis of Efinaconazole
Figure 73. Industry Chain Structure of Efinaconazole
Figure 74. Channels of Distribution
Figure 75. Global Efinaconazole Sales Market Forecast by Region (2026-2031)
Figure 76. Global Efinaconazole Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Efinaconazole Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Efinaconazole Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Efinaconazole Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Efinaconazole Revenue Market Share Forecast by Application (2026-2031)